United States Department of Veterans Affairs
Research Advisory Committee on Gulf War Veterans' Illnesses

Research Update - July 2005

 

The following journal articles were distributed for review in July 2005.  You can access the article's abstract by copying the paper title and pasting it into the search bar of the PubMed website, linked here. 


Research Relevant to Gulf War Service and Exposures
 
1. Study of the reproductive effects in rats surgically implanted with depleted uranium for up to 90 days.  (Arfsten DP, et al.  J Toxicol Environ Health A.  Jun 2005; 68(11): 967-997)
 
2. Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction.   (Bullman TA, et al.  Am J Public Health.  Aug 2005; 95(8): 1382-1388)
 
3. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.  (Cole TB, et al.   Pharmacogenet Genomics.  Aug 2005; 15(8): 589-598)
 
4. Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures.(Dabisch PA, et al.  J Ocul Pharmacol Ther.  Jun 2005; 21(3): 182-195)
 
5. Pyrethroid pesticide-induced alterations in dopamine transporter function.   (Elwan MA, et al.  Toxicol Appl Pharmacol.  Jul 7, 2005; [Epub ahead of print])
 
6. Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson’s disease.  (Fong CS, et al.   Acta Neurol Taiwan  .  Jun 2005; 14(2): 55-60)
 
7. Paraoxonase 1 (PON1) status and risk of insecticide exposure.  (Furlong CE, et al.  J Biochem Mol Toxicol.  2005; 19(3): 182-183)
 
8. Increased evidence of testicular cancer among veterans of the 1991 Gulf War.   (Gray GC.  Mil Med.  May 2005; 170(5): 394)
 
9. Gulf War Syndrome – the story so far.  (Greenberg N, Wessely S.  J R Nav Med Serv.  2005; 91(1): 4-11)
 
10. Late respiratory complications of mustard gas poisoning in Iranian veterans.  (Hefazi M, et al.  Inhal Toxicol.  Oct 2005; 17(11): 587-592)
 
11. Leveraging existing database to study vehicle crashes in a combat occupational cohort: Epidemiologic methods.   (Hooper TI, et al.  Am J Ind  Med.  Jul 19, 2005; 118-127)
 
12. Enriched but not depleted uranium affects central nervous system in long-term exposed rat.   (Houpert P.  Neurotoxicology.  Jul 1, 2005; [Epub ahead of print])
 
13. Going to war does not have to hurt: preliminary findings from the British deployment to Iraq.  (Hughes JH, et al.  Br J Psychiatry.  Jun 2005; 186: 536-537)
 
14. Commentary: Adding to our comprehension of Gulf War health questions.  (Hyams KC.  Int J Epidemiol.  Jun 21, 2005; [Epub ahead of print])
 
15. Increased psychological distress among Danish gulf war veterans – without evidence for a neurotoxic background – The Danish Gulf War Study.  (Ishoy T, et al.  Dan Med Bull .  Feb 2004; 51(1): 108-113)
 
16. Concentration and characteristics of depleted uranium in water, air and biological samples collected in Serbia and Montenegro.  (Jia G, et al.  Appl Radiat Isot.  Jul 2, 2005: [Epub ahead of print])
 
17. Soldier peer mentoring care and support: bringing psychological awareness to the front.  (Keller RT, et al.  Mil Med.  May 2005; 170(5): 355-361)
 
18. Clinical outcomes of Gulf veterans’ medical assessment programme referrals to specialized centers for Gulf veterans with post-traumatic stress disorder.   (Lee HA, et al.  Mil Med.  May 2005; 170(5): 400-405)
 
19. Combat casualty care: the Alpha Surgical Company experience during Operation Iraqi Freedom.  (Marshall TJ Jr.  Mil Med.  Jun 2005; 170(6): 469-472)
 
20. Reported stressors and health care needs of active duty Navy personnel during three phases of deployment in support of the war in Iraq.   (McNulty PA.  Mil Med.  Jun 2005; 170(6): 530-535)
 
21. Effects of depleted uranium on survival, growth, and metamorphosis in the African clawed frog (Xenopus laevis).  (Mitchell SE, et al.  J Toxicol Environ Health A.  Jun 2005; 68(11): 951-965)
 
22. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo.   (Perrier NA, et al.  J Neurochem.  Aug 2005; 94(3): 629-638)
 
23. Monitoring the health of Persian Gulf War veteran women.  (Pierce PF.  Mil Med.  May 2005; 170(5): 349-354)
 
24. Paraoxonase polymorphisms and self-reported chronic ill-health in farmers dipping sheep.   (Povey AC, et al.  Occup Med (Lond).  Jun 2005; 55(4): 282-286)
 
25. Spatial analysis of 1991 Gulf War troop locations in relationship with postwar health symptom reports using GIS techniques.  (Proctor SP, et al.  Transactions in GIS.  2005; 9(3): 381-396)
 
26. In vivo effects of chronic contamination with depleted uranium on CYP3A and associated nuclear receptors PXR and CAR in the rat.  (Souidi M, et al.  Toxicology.  Jul 20, 2005; [Epub ahead of print])
 
27. Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine’s association with Gulf War syndrome?  (Staines D.  Med Hypotheses.  2005; 65(3): 591-594)
 
28. Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?  (Staines D.  Med Hypotheses.  July 15, 2005; [Epub ahead of print])
 
29. Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders.  (Staines DR  .  Med Hypotheses.  2005; 65(4): 797-803)
 
30. Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation.   (Taysse L, et al.  Neurochem Res.  Mar 2005; 30(3): 391-402)
 
31. Dermal absorption of permethrin following topical administration.  (Tomalik-Scharte D, et al.  Eur J Clin Pharmacol.  Jun 10, 2005; [Epub ahead of print])
 
32. Survey of repellent use by service members arriving in Kuwait for Operation Iraqi Freedom 2.  (White DJ, et al.  Mil Med.  Jun 2005; 170(6): 496-500)
 
Research on Evaluation/Treatment of Chronic Multisymptom Illnesses
 
1. A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia.  (Assefi NP, et al.  Ann Intern Med.  Jul 5, 2005; 143(1): 10-19)
 
2. Fibromyalgia and complementary and alternative medicine.  (Bartecchi CE.  Mayo Clin Proc.  Jun 2005; 80(6): 826; author reply 826-827)
 
3. A description of a brief multidisciplinary treatment program for fibromyalgia.  (Luedtke  CA  , et al.  Pain Manag Nurs.  Jun 2005; 6(2): 76-80)
 
4. Predictors of pain behaviors in fibromyalgia syndrome.  (Thieme K, et al.  Arthritis Rheum.  Jun 2, 2005; 53(3): 343-350)
 

Back to Previous Research Updates